Igf-1 Lr3 Storage Guidelines

Q: What is the primary mechanism of Long R3 IGF-1 compared to native IGF-1?

Long R3 IGF-1 features an Arg3 substitution and a 13-amino-acid N-terminal extension. This structural alteration dramatically reduces its binding affinity for endogenous IGFBPs while maintaining affinity for the Type 1 IGF receptor.

Q: How does IGF-1 LR3 storage stability compare to growth hormone secretagogues?

IGF-1 LR3 is a larger, folded recombinant protein requiring acidic reconstitution buffers and ultra-cold long-term storage. Smaller secretagogues like CJC-1295 or Ipamorelin are less complex and generally exhibit longer solution stability in neutral reconstituted media.

Navigating the storage and handling of recombinant peptides requires precise environmental controls to maintain molecular integrity and experimental reproducibility. This technical reference details the official IGF-1 LR3 storage guidelines for lyophilized and reconstituted states within preclinical research environments. Researchers can utilize these parameters to minimize peptide degradation, prevent aggregation, and ensure analytical accuracy across in vitro assays.

GMP-compliant U.S. facilities

ISO 17025 third-party COAs

100% domestic — no imports

Fast tracked domestic shipping

Shop research peptides

Quick answer

Reviewed by PX1 Research scientific team

Key takeaways

Lyophilized [IGF-1 LR3](/research-peptides/igf-1-lr3) must be stored desiccated at -20°C to -80°C for long-term stability (up to 24 months), or at 2°C to 8°C for short-term benchwork under 30 days.
Long R3 IGF-1 ([IGF-1 LR3](/research-peptides/igf-1-lr3)) is an 83-amino-acid analog of human Insulin-Like Growth Factor-1.
Upon receipt, lyophilized [IGF-1 LR3](/research-peptides/igf-1-lr3) standard vials should be inspected and immediately placed into dedicated low-temperature storage.
Selecting the correct reconstitution matrix is a critical factor governing reconstituted [IGF-1 LR3](/research-peptides/igf-1-lr3) stability.

Standard IGF-1 LR3 Storage Guidelines Summary

Lyophilized IGF-1 LR3 must be stored desiccated at -20°C to -80°C for long-term stability (up to 24 months), or at 2°C to 8°C for short-term benchwork under 30 days. Once reconstituted in an acidic vehicle such as 10–100 mM acetic acid or bacteriostatic water, aliquoted solutions remain stable at 2°C to 8°C for 2 to 3 weeks, or at -80°C for up to 6 months. Repeated freeze-thaw cycles and non-acidic aqueous storage must be strictly avoided.

Maintaining structural integrity during experimental workflows is essential when evaluating high-purity compounds. Researchers reviewing our catalog of all peptides should establish rigorous thermal and atmospheric protocols from the moment of receipt. Proper adherence to recommended temperatures prevents thermal denaturation and ensures that the extended half-life characteristic of Long R3 IGF-1 remains uncompromised during biochemical evaluations.

Because IGF-1 LR3 is engineered with an extended amino acid sequence designed to reduce binding protein affinity, its secondary and tertiary structures are sensitive to thermal exposure and pH fluctuations. Proper storage conditions ensure that batch-to-batch uniformity is maintained across sequential in vitro assays and cell culture models.

Molecular Architecture and Stability Parameters of Long R3 IGF-1

Long R3 IGF-1 (IGF-1 LR3) is an 83-amino-acid analog of human Insulin-Like Growth Factor-1. It incorporates a substitution of Glutamic acid by Arginine at position 3, alongside a 13-amino-acid N-terminal extension peptide. In native IGF-1, endogenous Insulin-like Growth Factor Binding Proteins (IGFBPs) bind the peptide with high affinity, neutralizing its bioactivity and accelerating clearance. The molecular modifications in IGF-1 LR3 markedly reduce affinity for IGFBPs, resulting in significantly greater free peptide availability in preclinical research media.

However, this extended sequence also introduces additional physical and chemical vectors for potential degradation. The primary polypeptide chain contains disulfide bonds that are crucial for maintaining proper tertiary folding required for Type 1 IGF receptor (IGF-1R) activation. In vitro studies demonstrate that exposing the peptide to room temperature or elevated pH environments can disrupt these structural bonds or catalyze side-chain modifications. For detailed structural specifications, researchers can reference our dedicated IGF-1 LR3 product page.

Understanding these biochemical properties highlights why standardized handling is necessary. The tertiary structure remains stable under desiccated, sub-zero conditions, but becomes increasingly vulnerable once placed in aqueous buffer systems, particularly those with neutral or alkaline pH levels.

Lyophilized Powder Storage Protocols: Thermal and Atmospheric Control

Upon receipt, lyophilized IGF-1 LR3 standard vials should be inspected and immediately placed into dedicated low-temperature storage. For long-term archive storage exceeding 1 to 2 months, maintaining temperatures between -20°C and -80°C is required. Under these ultra-low temperature conditions, the desiccated cake remains stable for up to 24 months without measurable loss of analytical purity.

If the lyophilized peptide is scheduled for immediate use within an active experimental protocol (under 30 days), storage in a standard laboratory refrigerator at 2°C to 8°C is acceptable, provided the vial remains sealed in a desiccated container. Moisture intrusion is the leading cause of premature degradation in lyophilized powders. atmospheric humidity inside cold rooms can cause moisture to condense inside the vial if it is opened prior to thermal equilibration.

To prevent condensation, vials retrieved from deep freeze (-20°C or -80°C) must be allowed to equilibrate to room temperature on the benchtop inside a desiccator before opening the stopper. This simple step prevents hygroscopic pickup, which can otherwise trigger rapid hydrolysis and aggregation prior to formal reconstitution.

Reconstitution Chemistry: Selecting Appropriate Buffers and Diluents

Selecting the correct reconstitution matrix is a critical factor governing reconstituted IGF-1 LR3 stability. Unlike simple linear peptides, IGF-1 LR3 exhibits optimum solubility and structural stability in mildly acidic conditions. Standard recommendation calls for initial reconstitution in sterile 10 mM to 100 mM (0.1%) dilute acetic acid to yield a stock concentration between 0.1 mg/mL and 1.0 mg/mL.

Initial solubilization in acidic media ensures total dissolution of the peptide cake and stabilizes the primary tertiary structure. Once fully dissolved in dilute acetic acid, the stock solution can be further diluted into neutral cell culture media or phosphate-buffered saline (PBS) containing 0.1% Bovine Serum Albumin (BSA) or Human Serum Albumin (HSA) immediately prior to in vitro administration. The carrier protein (BSA/HSA) prevents non-specific adsorption of the hydrophobic peptide to container walls.

Reconstitution directly in neutral PBS or unbuffered sterile water without an acidic phase frequently results in incomplete dissolution, rapid aggregation, or surface adsorption. For researchers interested in comparative stability dynamics among modified analogs, reviewing findings on IGF-1 DES mechanisms provides valuable context on how structural truncations alter buffer sensitivity.

Storage of Reconstituted IGF-1 LR3 Solutions

Once reconstituted according to laboratory protocols, the liquid peptide solution exhibits a reduced stability timeline compared to its lyophilized counterpart. Reconstituted stock solutions prepared in 0.1% acetic acid with a carrier protein maintain analytical integrity for up to 21 days when stored continuously at 2°C to 8°C.

For extended liquid storage beyond 3 weeks, working solutions must be aliquoted into single-use microcentrifuge tubes and frozen at -80°C. Frozen aliquots preserved in this manner maintain stable binding affinity and purity profiles for up to 6 months. Storing reconstituted peptide solutions at standard benchtop temperatures (20°C to 25°C) leads to rapid activity loss within 24 to 48 hours.

In instances where long-term culture projects require preserved sterile solutions, research facilities often consult our wholesale portal to coordinate large-batch procurement with consistent lot numbers, ensuring that storage conditions remain uniform across long-term experimental series.

Degradation Mechanisms: Oxidation, Deamidation, and Aggregation

Understanding the pathways through which IGF-1 LR3 degrades allows research teams to implement preventative handling procedures. The three primary pathways responsible for peptide decay in solution are oxidation, deamidation, and hydrophobic aggregation.

Oxidation primarily targets methionine and cysteine residues present in the IGF-1 LR3 sequence. Exposure to dissolved oxygen, light, or trace metal ions accelerates methionine sulfoxide formation, altering receptor-binding capacity. Deamidation occurs predominantly at asparagine and glutamine residues, especially when liquid solutions are maintained at neutral or basic pH levels above 7.0.

Aggregation occurs when partially unfolded hydrophobic regions of the peptide associate to form insoluble oligomers. Physical agitation, such as vigorous vortexing, introduces air-water interfaces that trigger rapid aggregation. Therefore, reconstituted IGF-1 LR3 should always be gently swirled or inverted rather than vortexed during preparation.

Freeze-Thaw Sensitivity and Micro-Aliquoting Strategies

Repeated freeze-thaw cycles represent one of the most destructive physical stresses imposed on reconstituted peptide solutions. Ice crystal growth during slow freezing and localized ice melting during thawing generate shear forces and pH shifts that denature the peptide's tertiary structure.

To eliminate freeze-thaw damage, laboratories should enforce a strict micro-aliquoting protocol. Immediately following initial reconstitution, the stock solution should be divided into single-use volumes (e.g., 20 µL to 50 µL) tailored to daily assay needs. Individual micro-vials are then frozen once at -80°C.

When an aliquot is required for an in vitro experiment, it is thawed once on ice, utilized immediately, and any residual liquid is discarded. Under no circumstances should a thawed liquid aliquot be returned to the freezer for future use. Adopting this protocol ensures consistent bioactivity across all experimental replicates.

Comparative Stability Profile: IGF-1 LR3 vs. Native IGF-1, IGF-1 DES, and Secretagogues

When designing research studies involving the somatotropic axis, investigators often compare IGF-1 LR3 against related compounds in the growth factor and secretagogue categories. Each class presents distinct stability characteristics, buffer demands, and half-life parameters in laboratory models.

For instance, truncated analogs like IGF-1 DES lack the 13-amino-acid extension found in LR3, altering both its isoelectric point and its susceptibility to physical aggregation. Meanwhile, growth hormone secretagogues such as CJC-1295 No DAC and Ipamorelin possess much smaller linear amino acid chains. While these secretagogues are generally less prone to complex tertiary unfolding, they remain susceptible to hydrolytic cleavage if stored in non-buffered aqueous solutions.

The table below outlines key stability parameters comparing these classes within research environments:

Quality Verification: COA, RP-HPLC, and Endotoxin Standards

Experimental integrity depends not only on proper storage but also on starting with verified high-purity material. Inferior manufacturing, residual salts, or structural impurities directly degrade storage stability and produce inconsistent experimental outcomes.

At PX1 Research, every production lot of IGF-1 LR3 undergoes rigorous quality control in ISO 17025 accredited analytical laboratories located in the USA. We utilize Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to verify chemical purity levels exceeding 98%, and Electrospray Ionization Mass Spectrometry (ESI-MS) to confirm exact molecular weight and amino acid sequence fidelity.

Furthermore, because bacterial endotoxins can introduce confounding inflammatory responses in cell culture models, all lots undergo Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain strictly controlled under 0.1 EU/mg. Every shipment includes lot-traceable Documentation accessible through our public research documentation repository, providing full transparency for regulatory compliance and audit trails.

Laboratory Environmental Controls and Container Selection

In addition to temperature control, secondary environmental factors must be regulated during long-term storage of IGF-1 LR3. Photolytic degradation can occur when aqueous peptide solutions are exposed to direct sunlight or high-intensity UV laboratory lighting. Vials should be kept in opaque boxes or light-blocking storage containers.

Container wall material is another frequently overlooked variable. Standard untreated glass or low-grade polystyrene containers present high surface binding potential, causing hydrophobic peptides like IGF-1 LR3 to adhere to the container walls and rapidly drop out of solution. Researchers should strictly utilize low-binding polypropylene microcentrifuge tubes or silanized glass vials for all storage and dilution steps.

Implementing these standard operating procedures ensures that experimental variance remains low, protecting both historical data integrity and prospective analytical trial validity across all preclinical research protocols.

Frequently Asked Questions

What are the recommended temperature ranges for storing lyophilized IGF-1 LR3?

Lyophilized IGF-1 LR3 should be stored at -20°C to -80°C for long-term stability up to 24 months. For short-term experimental work under 30 days, storage at 2°C to 8°C in a desiccated container is acceptable.

How long does reconstituted IGF-1 LR3 remain stable in solution?

When reconstituted in dilute acetic acid (10–100 mM) with 0.1% BSA carrier protein, IGF-1 LR3 solutions remain stable at 2°C to 8°C for 2 to 3 weeks. If aliquoted and frozen at -80°C, solutions remain stable for up to 6 months.

Why is dilute acetic acid recommended over plain sterile water for reconstitution?

IGF-1 LR3 exhibits optimal solubility and structural stability in mildly acidic conditions (pH 3.0–4.0). Reconstituting directly in plain neutral water or PBS often results in incomplete dissolution, rapid aggregation, and binding to container surfaces.

Can reconstituted IGF-1 LR3 undergo repeated freeze-thaw cycles?

No. Freeze-thaw cycles cause mechanical shear forces and localized pH shifts that denature the peptide's tertiary structure. Stock solutions must be divided into single-use aliquots before initial freezing.

What type of vials or tubes should be used for storing IGF-1 LR3 solutions?

Researchers should use low-binding polypropylene microcentrifuge tubes or silanized glass vials. Standard glass or polystyrene can cause hydrophobic surface adsorption, lowering effective solution concentration.

How do I verify the purity and quality of PX1 Research IGF-1 LR3?

PX1 Research provides lot-specific Certificates of Analysis (COA) incorporating RP-HPLC for purity (>98%), Mass Spectrometry for sequence verification, and LAL testing for endotoxin levels (<0.1 EU/mg).

What is the primary mechanism of Long R3 IGF-1 compared to native IGF-1?